Stem cell transplantation for treatment of sickle cell disease: Bone marrow versus cord blood transplants

American Journal of Health-System Pharmacy

Volumn 69, Issue 15, 2012, Pages 1295-1302

  Thompson, Lisa Marie ^a   Ceja, Maria Estela ^b   Yang, Sonal Patel ^c  

^a Banner MD Anderson Cancer Center   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c Norman Regional Health System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; ANTICONVULSIVE AGENT; BUSULFAN; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOGLOBIN; HEMOGLOBIN S; HYDROXYUREA; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENICILLIN DERIVATIVE; PHENYTOIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ANEMIA; ANTIBIOTIC PROPHYLAXIS; ASPLENIA; BLOOD TRANSFUSION; BONE MARROW; BONE MARROW SUPPRESSION; CLINICAL PRACTICE; DACTYLITIS; DECISION MAKING; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; ELECTROLYTE DISTURBANCE; ERYTHROCYTE TRANSFUSION; EVENT FREE SURVIVAL; EXCHANGE BLOOD TRANSFUSION; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HAEMOPHILUS INFLUENZAE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOGLOBIN BLOOD LEVEL; HLA MATCHING; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INFERTILITY; INTERMETHOD COMPARISON; LEUKOCYTOSIS; MAGNESIUM BLOOD LEVEL; MUCOSA INFLAMMATION; MYELOABLATIVE CONDITIONING; NEISSERIA MENINGITIDIS; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; OVERALL SURVIVAL; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SEIZURE; SEPTICEMIA; SICKLE CELL ANEMIA; STEM CELL TRANSPLANTATION; STREPTOCOCCUS PNEUMONIAE; STROKE; TREATMENT OUTCOME; UMBILICAL CORD BLOOD; VACCINATION; WHOLE BODY RADIATION;

EID: 84865959970     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp110308     Document Type: Review

References (37)

1. Centers for Disease Control and Prevention. Sickle cell disease. www.cdc.gov/ncbddd/sicklecell/index.html (accessed 2011 May 1).
2. Smiers FJ, Krishnamurti L, Lucarelli G. Hematopoietic stem cell transplantation for hemoglobinopathies: current practice and emerging trends. Pediatr Clin North Am. 2010; 57:181-205.
3. National Heart, Lung, and Blood Institute. What is sickle cell anemia? www.nhlbi.nih.gov/health/dci/Diseases/Sca/SCA-WhatIs.html (accessed 2011 May 1).
4. Johnson FL, Look AT, Gockerman J et al. Bone marrow transplantation in a patient with sickle cell anemia. N Engl J Med. 1984; 311:780-3. (Pubitemid 14026230)
5. Walters MC, Patience M, Leisenring W et al. Barriers to bone marrow transplant for sickle cell anemia. Biol Blood Marrow Transplant. 1996; 2:100-4. (Pubitemid 126488201)
6. Goerner M, Gooley T, Flowers M et al. Morbidity and mortality of chronic GVHD after hematopoietic stem cell transplant from HLA-identical siblings for patients with aplastic or refractory anemias. Biol Blood Marrow Transplant. 2002; 8:47-56. (Pubitemid 34141551)
7. Platt OS. Hydroxyurea for the treatment of sickle cell anemia. N Engl J Med. 2008; 358:1362-9.
8. Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet. 2010; 376:2018-31.
9. Hydrea (hydroxyurea) package insert. Princeton, NJ: Bristol-Myers Squibb Company; 2001 Mar.
10. Booth C, Inusa B, Obaro SK. Infection in sickle cell disease: a review. Int J Infect Dis. 2010; 14:e2-12.
11. Dick MC. Standards for the management of sickle cell disease in children. Arch Dis Child Educ Pract Ed. 2008; 93:169-76.
12. O'Brien SH, Hankins JS. Decision analysis of treatment strategies in children with severe sickle cell disease. J Pediatr Hematol Oncol. 2009; 31:873-8.
13. Krishnamurti L. Hematopoietic cell transplantation for sickle cell disease: state of the art. Expert Opin Biol Ther. 2007; 7:161-72. (Pubitemid 46192165)
14. Miller ST, Sleeper LA, Pegelow CH et al. Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med. 2000; 342:83-9. (Pubitemid 30036599)
15. Walters MC, Patience M, Leisenring W et al. Bone marrow transplantation for sickle cell disease. N Engl J Med. 1996; 335:369-76. (Pubitemid 26257244)
16. Atkins RC, Walters MC. Haematopoietic cell transplantation in the treatment of sickle cell disease. Expert Opin Biol Ther. 2003; 3:1215-24. (Pubitemid 38004692)
17. Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med. 2006; 354:1813-26.
18. Bhatia M, Walters MC. Hematopoietic cell transplantation for thalassemia and sickle cell disease: past, present and future. Bone Marrow Transplant. 2008; 41:109-17. (Pubitemid 351188907)
19. Iannone R, Ohene-Frempong K, Fuchs EJ et al. Bone marrow transplantation for sickle cell anemia: progress and prospects. Pediatr Blood Cancer. 2005; 44:436-40. (Pubitemid 40614490)
20. Peters C, Cornish JM, Parikh SH et al. Stem cell source and outcome after hematopoietic stem cell transplantation (HSCT) in children and adolescents with leukemia. Pediatr Clin North Am. 2010; 57:27-46.
21. Asia Y, Nakazato T, Shimizu T et al. Effects of immunosuppressive agents on magnesium metabolism early after allogenic hematopoietic stem cell transplantation. Transplantation. 2005; 80:1046-50. (Pubitemid 41611926)
22. Rizzo JD, Wingard JR, Tichelli A et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Bone Marrow Transplantation, the Center for International Blood and Marrow Transplantation Research, and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2006; 12:138-51. (Pubitemid 43138009)
23. Walters MC, Storb R, Patience M et al. Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease. Blood. 2000; 95:1918-24. (Pubitemid 30151626)
24. Walters MC, Sullivan KM, Bernaudin F et al. Neurologic complications after allogeneic marrow transplantation for sickle cell anemia. Blood. 1995; 85:879-84.
25. Rosenbaum C, Peace D, Rish E et al. Granulocyte colony-stimulating factor-based stem cell mobilization in patients with sickle cell disease. Biol Blood Marrow Transplant. 2008; 14:719-23. (Pubitemid 351664057)
26. Vermylen C, Cornu G, Ferster A et al. Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium. Bone Marrow Transplant. 1998; 22:1-6. (Pubitemid 28330528)
27. Panepinto JA, Walters MC, Carreras J et al. Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Marrow Transplant Research. Br J Haematol. 2007; 137:479.
28. Iannone R, Casella JF, Fuchs EJ et al. Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and β-thalassemia. Biol Blood Marrow Transplant. 2003; 9:519-28. (Pubitemid 38351796)
29. Bernaudin F, Socie G, Kuentz M et al. Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease. Blood. 2007; 110:2749-56. (Pubitemid 47523201)
30. Bolanos-Meade J, Brodsky RA. Blood and marrow transplantation for sickle cell disease: overcoming barriers to success. Curr Opin Oncol. 2009; 21:158-61.
31. Gore L, Lane PA, Quinones RR et al. Successful cord blood transplantation for sickle cell anemia from a sibling who is human leukocyte antigen-identical: implications for comprehensive care. J Pediatr Hematol Oncol. 2000; 22:437-40. (Pubitemid 33599752)
32. Gluckman E, Broxmeyer HA, Auerbach AD et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med. 1989; 321:1174-8. (Pubitemid 19255814)
33. Brunstein CG, Weisdorf DJ. Future of cord blood for oncology uses. Bone Marrow Transplant. 2009; 44:699-707.
34. Locatelli F, Rocha V, Reed W et al. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood. 2003; 101:2137-43. (Pubitemid 36302049)
35. Locatelli F, Rocha V, Chastang C et al. Factors associated with outcome after cord blood transplantation in children with acute leukemia. Blood. 1999; 93:3662-71. (Pubitemid 29249812)
36. Adamkiewicz TV, Szabolcs P, Haight A et al. Unrelated cord blood transplantation in children with sickle cell disease: review of four-center experience. Pediatr Transplant. 2007; 11:641-4. (Pubitemid 47174392)
37. Adamkiewicz TV, Boyer MW, Bray R et al. Identification of unrelated cord blood units for hematopoietic stem cell transplantation in children with sickle cell disease. J Pediatr Hematol Oncol. 2006; 28:29-32. (Pubitemid 43361615)